Holen Sie sich die Stockscreener-App
3.68
4.42%
-0.17
Handel nachbörslich:
3.80
0.12
+3.26%
Schlusskurs vom Vortag:
$3.85
Offen:
$3.85
24-Stunden-Volumen:
49,552
Relative Volume:
0.93
Marktkapitalisierung:
$244.49M
Einnahmen:
$64.49M
Nettoeinkommen (Verlust:
$-71.40M
KGV:
-3.3761
EPS:
-1.09
Netto-Cashflow:
$-52.00M
1W Leistung:
+1.38%
1M Leistung:
+27.34%
6M Leistung:
+13.58%
1J Leistung:
-23.33%
1-Tages-Spanne:
$3.68
$3.85
1-Wochen-Bereich:
$3.51
$3.9276
52-Wochen-Spanne:
$2.70
$7.37
Sophia Genetics Sa Stock (SOPH) Company Profile
Firmenname
Sophia Genetics Sa
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SOPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
3.68 | 244.49M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
234.33 | 38.04B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
74.94 | 14.06B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.65 | 12.72B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
71.21 | 11.21B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.50 | 9.75B | 1.15B | 96.70M | -161.99M | 1.09 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-18 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-03 | Eingeleitet | BTIG Research | Buy |
| 2022-11-23 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-17 | Eingeleitet | Cowen | Outperform |
| 2021-08-17 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-17 | Eingeleitet | JP Morgan | Overweight |
| 2021-08-17 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten
SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 4.4% – Here’s Why - Defense World
Analyzing Caribou Biosciences (NASDAQ:CRBU) & SOPHiA GENETICS (NASDAQ:SOPH) - Defense World
Clear Channel Outdoor Holdings Inc (CCO) Shares Plummet Below 1-Year High - The News Heater
SOPHiA Genetics SA (SOPH) Stock: Analyzing the Market Value - The News Heater
Anavex Life Sciences Corporation (AVXL) Stock: Assessing the Risk and Reward - The News Heater
Stock market today: Haoxi Health Technology -30.00%, Planet Image International -26.26% among biggest losers in early trading - Business Upturn
SOPHSOPHiA GENETICS SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities -January 28, 2025 at 08:47 am EST - Marketscreener.com
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities – Company Announcement - Financial Times
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities - Barchart
Game-Changing Cancer Detection Tool Spots What Others Miss: New Breakthrough from SOPHiA GENETICS - StockTitan
Tempus AI Stock Before Q4 Earnings: To Buy Or Not To Buy? - Barchart
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Bioinformatics Market Analysis: Key Trends, Growth Drivers and Key Companies 2025 – 2032 - Newstrail
AI In Genomics Global Market Report 2024: Exponential Market - openPR
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Decreases By 15.1% - MarketBeat
3 US Penny Stocks With Market Caps Under $200M - Simply Wall St
Shareholders Should Be Pleased With SOPHiA GENETICS SA's (NASDAQ:SOPH) Price - Simply Wall St
Genomic Biomarkers Market Report: Personalized Medicine - GlobeNewswire
Genomic Biomarkers Market Report: Personalized Medicine Powers 17.4% CAGR in Genomic Biomarkers Through 2028 - Yahoo Finance
The Zacks Analyst Blog Highlights Tempus AI, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance
Tempus AI Stock Surges 23% In 6 Months: Should You Snap It Up Now? - Barchart
Radiomics Market Top Companies StudyRadiomics.io - openPR
Principal Financial Group Inc. Buys 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
JPMorgan Chase & Co. Purchases 1,399,131 Shares of iShares 5-10 Year Investment Grade Corporate Bond ETF (NASDAQ:IGIB) - Defense World
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 38.6% - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Coverage Initiated at Craig Hallum - Defense World
Guggenheim Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy Recommendation - MSN
Growth Trends in Europe's Precision Medicine Software - GlobeNewswire
Growth Trends in Europe's Precision Medicine Software Market: Focus on Product Type, Application, End User, and CountryAnalysis and Forecast, 2024-2033 - GlobeNewswire
SOPHiA GENETICS (NASDAQ:SOPH) Now Covered by Analysts at Craig Hallum - MarketBeat
Craig-Hallum Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy Recommendation - MSN
SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth - Investing.com Australia
SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth By Investing.com - Investing.com South Africa
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
Precision Medicine Software Market to Witness Substantial Growth and New Opportunities from 2024 to 2031 As... - WhaTech
US Penny Stocks To Watch In December 2024 - Simply Wall St
Bioinformatics Market to Grow by USD 13.2 Billion (2024-2028), Lower Genetic Sequencing Costs Drive Revenue, Report Highlights AI's Role in TransformationTechnavio - The Malaysian Reserve
SOPHiA GENETICS Reports Third Quarter 2024 Results - GuruFocus.com
Principal Financial Group Inc. Acquires 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024 – Company Announcement - Financial Times
SOPHiA GENETICS Launches Advanced Cancer Profiling Platform with 99.3% Accuracy - StockTitan
SOPHiA GENETICS's SWOT analysis: data-driven medicine stock faces headwinds - Investing.com India
SOPHiA GENETICS (NASDAQ:SOPH) vs. SpringWorks Therapeutics (NASDAQ:SWTX) Financial Review - Defense World
Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00 - Yahoo Finance
SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: SOPHiA GENETICS reported a16% year-over-year increase in analysis volume - Investing.com
SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS Q3 2024 Financial Highlights - TipRanks
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer - Marketscreener.com
Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.00%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):